Tamanoi, Fuyuhiko

Light‐Activated Nanoimpeller‐Controlled Drug Release in Cancer Cells

Lu, J., Choi, E., Tamanoi, F., & Zink, J. I. (2008) · Small

Nanoplatforms for cancer theranosticsNanoparticle-Based Drug Delivery

Cited by 462

Identification of Ras farnesyltransferase inhibitors by microbial screening.

Hara, M., Akasaka, K., Akinaga, S., Okabe, M., Nakano, H., Gomez, R., Wood, D., Uh, M., & Tamanoi, F. (1993) · Proceedings of the National Academy of Sciences

Microbial Natural Products and BiosynthesisProtein Kinase Regulation and GTPase Signaling

Cited by 257

Specific Activation of mTORC1 by Rheb G-protein in Vitro Involves Enhanced Recruitment of Its Substrate Protein

Sato, T., Nakashima, A., Guo, L., & Tamanoi, F. (2009) · Journal of Biological Chemistry

PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase Signaling

Cited by 196

Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery

Klichko, Y., Liong, M., Choi, E., Angelos, S., Nel, A. E., Stoddart, J. F., Tamanoi, F., & Zink, J. I. (2009) · Journal of the American Ceramic Society

Mesoporous Materials and CatalysisAerogels and thermal insulation

Cited by 116

Development of Mesoporous Silica Nanomaterials As a Vehicle for Anticancer Drug Delivery

Yanes, R. E., & Tamanoi, F. (2012) · Therapeutic Delivery

Nanoparticle-Based Drug DeliveryMesoporous Materials and Catalysis

Cited by 68

Rheb G-Proteins and the Activation of mTORC1

Parmar, N., & Tamanoi, F. (2010) · The Enzymes

PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase Signaling

Cited by 41